InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Robin Shane Readnour, Director, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 10 open-market SEC Form 4 transactions: 8 purchases worth $1.5M and 2 sales worth $57K, reported from Mar 29, 22 to Dec 10, 24. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 10, 24 | ANTXAN2 Therapeutics, Inc. | BUY | 5.0K | $1.49 | $7K |
| Dec 9, 24 | ANTXAN2 Therapeutics, Inc. | BUY | 18.5K | $1.43 | $26K |
| Dec 6, 24 | ANTXAN2 Therapeutics, Inc. | BUY | 12.7K | $1.45 | $18K |
| Nov 27, 24 | ANTXAN2 Therapeutics, Inc. | BUY | 25.0K | $1.42 | $36K |
| Nov 26, 24 | ANTXAN2 Therapeutics, Inc. | BUY | 12.5K | $1.39 | $17K |
| Nov 20, 24 | ANTXAN2 Therapeutics, Inc. | BUY | 25.0K | $1.15 | $29K |
| Nov 19, 24 | ANTXAN2 Therapeutics, Inc. | BUY | 75.0K | $1.04 | $78K |
| Jan 12, 24 | ANTXAN2 Therapeutics, Inc. | SELL | 719 | $21.92 | $16K |
| Jan 10, 24 | ANTXAN2 Therapeutics, Inc. | SELL | 1.9K | $21.93 | $41K |
| Mar 29, 22 | ANTXAN2 Therapeutics, Inc. | BUY | 82.6K | $15.00 | $1.2M |